Literature DB >> 21298639

The effects of cigarette smoke condensate on vocal fold transepithelial resistance and inflammatory signaling in vocal fold fibroblasts.

Ryan C Branski1, Hang Zhou, Dennis H Kraus, Mahalakshmi Sivasankar.   

Abstract

OBJECTIVES/HYPOTHESIS: In response to chronic cigarette smoke exposure, a subset of patients present with edematous vocal folds, characteristically referred to as Reinke's edema. This phenotype differs from the tissue changes associated with prolonged smoke exposure in the lower airway, and the mechanism underlying Reinke's edema remains poorly described. We hypothesize that the effects of smoke are diffuse and involve both the epithelium and mucosa. STUDY
DESIGN: In vitro, ex vivo experiment.
METHODS: Transepithelial resistance (R(T) ) was quantified in an ex vivo, viable, porcine vocal fold model. Excised tissue was exposed to cigarette smoke condensate (CSC) and R(T) was computed at baseline and 1 and 4 hours after exposure. In vitro, human vocal fold fibroblasts were exposed to CSC. Cyclooxygenase 2 (COX-2), microsomal prostaglandin E synthase-1, and 15-hydroxyprostaglandin dehydrogenase mRNA expression were assessed at 4 hours. Prostaglandin E2 (PGE2) synthesis was quantified via immunoassay following 24 hours of CSC exposure.
RESULTS: CSC had no effect on R(T) . CSC did, however, induce COX-2 mRNA expression as well as its downstream lipid mediator PGE2. PGE2 metabolism appears to be regulated via both synthetic and degradative enzymes in response to cigarette smoke.
CONCLUSIONS: In vitro, CSC initiates an inflammatory response in vocal fold fibroblasts. However, in isolation, the epithelial resistance is not altered by CSC, at least acutely. These data may suggest a role for the interaction between the inflammatory response in the mucosa and compromised epithelial barrier function, as has been shown in other tissues.
Copyright © 2011 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21298639      PMCID: PMC3132796          DOI: 10.1002/lary.21388

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  15 in total

1.  Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps.

Authors:  Masahiro Sonoshita; Kazuaki Takaku; Masanobu Oshima; Ken-ichi Sugihara; Makoto M Taketo
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

2.  Penetration of the respiratory epithelium of guinea pigs following exposure to cigarette smoke.

Authors:  A S Simani; S Inoue; J C Hogg
Journal:  Lab Invest       Date:  1974-07       Impact factor: 5.662

3.  Increased alveolar epithelial permeability in cigarette smokers.

Authors:  J G Jones; B D Minty; P Lawler; G Hulands; J C Crawley; N Veall
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary.

Authors:  R A Pauwels; A S Buist; P Ma; C R Jenkins; S S Hurd
Journal:  Respir Care       Date:  2001-08       Impact factor: 2.258

5.  Cigarette smoke inhibition of ion transport in canine tracheal epithelium.

Authors:  M J Welsh
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

6.  Hypertonic challenge to porcine vocal folds: effects on epithelial barrier function.

Authors:  Mahalakshmi Sivasankar; Elizabeth Erickson; Mark Rosenblatt; Ryan C Branski
Journal:  Otolaryngol Head Neck Surg       Date:  2009-11-22       Impact factor: 3.497

7.  Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer.

Authors:  Christine A Martey; Stephen J Pollock; Chantal K Turner; Katherine M A O'Reilly; Carolyn J Baglole; Richard P Phipps; Patricia J Sime
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-07-02       Impact factor: 5.464

8.  Regional respiratory clearance of aerosolized 99mTc-DTPA: posture and smoking effects.

Authors:  D J Dusser; B D Minty; M A Collignon; D Hinge; L G Barritault; G J Huchon
Journal:  J Appl Physiol (1985)       Date:  1986-06

Review 9.  Chronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesis.

Authors:  G L Snider
Journal:  Annu Rev Med       Date:  1989       Impact factor: 13.739

Review 10.  A new direction in the pathogenesis of idiopathic pulmonary fibrosis?

Authors:  Jack Gauldie; Martin Kolb; Patricia J Sime
Journal:  Respir Res       Date:  2001-09-26
View more
  6 in total

Review 1.  Vocal fold epithelial barrier in health and injury: a research review.

Authors:  Elizabeth Erickson Levendoski; Ciara Leydon; Susan L Thibeault
Journal:  J Speech Lang Hear Res       Date:  2014-10       Impact factor: 2.297

2.  Regulation of gene expression by tobacco product preparations in cultured human dermal fibroblasts.

Authors:  Gloria E Malpass; Subhashini Arimilli; G L Prasad; Allyn C Howlett
Journal:  Toxicol Appl Pharmacol       Date:  2014-06-10       Impact factor: 4.219

3.  Cigarette Smoke Exposure to Pig Larynx in an Inhalation Chamber.

Authors:  Xinxin Liu; Allison Mustonen; Wei Zheng; M Preeti Sivasankar; Abigail C Durkes
Journal:  J Voice       Date:  2018-07-05       Impact factor: 2.009

4.  Utility of cell viability assays for use with ex vivo vocal fold epithelial tissue.

Authors:  Elizabeth Erickson-DiRenzo; M Preeti Sivasankar; Susan L Thibeault
Journal:  Laryngoscope       Date:  2014-12-15       Impact factor: 3.325

5.  Vocal fold ion transport and mucin expression following acrolein exposure.

Authors:  Elizabeth Erickson Levendoski; M Preeti Sivasankar
Journal:  J Membr Biol       Date:  2014-03-20       Impact factor: 1.843

6.  Acute Acrolein Exposure Induces Impairment of Vocal Fold Epithelial Barrier Function.

Authors:  Xinxin Liu; Wei Zheng; M Preeti Sivasankar
Journal:  PLoS One       Date:  2016-09-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.